Status:
TERMINATED
Study to Evaluate the Safety and Efficacy of the Renal Assist Device in Patients With Acute Renal Failure
Lead Sponsor:
RenaMed Biologics
Conditions:
Kidney Failure, Acute
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
* The purpose of this study is to evaluate the safety and efficacy of the RAD to determine whether the RAD is effective in reducing mortality in patients with Acute Renal Failure due to Acute Tubule N...
Detailed Description
Acute Renal Failure (ARF)is a severe inflammatory disease state often accompanied by Multi-Organ Failure (MOF) and Systemic Inflammatory Response Syndrome (SIRS). ARF is precipitated by many factors a...
Eligibility Criteria
Inclusion
- A clinical diagnosis of Acute Tubular Necrosis (ATN)
- At least one non-renal organ failure
Exclusion
- A renal transplant at any time
- Chronic renal failure occurring due to reasons other than Acute Tubular Necrosis (ATN)
- Chronic
- Chronic immunosuppressive therapy
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00280072
Start Date
January 1 2006
End Date
August 1 2007
Last Update
December 3 2012
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35233
2
Denver Nephrologists, PC
Denver, Colorado, United States, 80230
3
George Washington University Hospital
Washington D.C., District of Columbia, United States, 20037
4
University of Chicago
Chicago, Illinois, United States, 60637